Solara Active Pharma Sciences Limited Total Liabilities
Solara Active Pharma Sciences Limited total liabilities. Based on the latest financial reports, Solara Active Pharma Sciences Limited (SOLARA) has total liabilities worth Rs10.36 Billion INR (≈ $112.04 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Solara Active Pharma Sciences Limited (SOLARA) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Solara Active Pharma Sciences Limited (2017–2025)
Total liabilities of Solara Active Pharma Sciences Limited from 2017 to 2025. This chart illustrates how Solara Active Pharma Sciences Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Solara Active Pharma Sciences Limited (SOLARA) long-term investment share to see how much of total assets are deployed in long-term investments.
Solara Active Pharma Sciences Limited Competitors by Total Liabilities
The table below lists competitors of Solara Active Pharma Sciences Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Orrön Energy AB (publ)
ST:ORRON
|
Sweden | Skr152.48 Million |
|
Zhubo Design
SHE:300564
|
China | CN¥332.68 Million |
|
Banvit Bandirma Vitaminli Yem Sanayi AS
IS:BANVT
|
Turkey | TL10.51 Billion |
|
Bukwang Pharm
KO:003000
|
Korea | ₩132.16 Billion |
|
Richmond Mutual Bancorporation Inc
NASDAQ:RMBI
|
USA | $1.40 Billion |
|
Te Chang Construction Co Ltd
TWO:5511
|
Taiwan | NT$7.01 Billion |
|
Kpx Holdings
KO:092230
|
Korea | ₩510.68 Billion |
|
Hylink Digital Solution Co Ltd
SHG:603825
|
China | CN¥2.37 Billion |
Liability Composition Analysis (2017–2025)
This chart breaks down Solara Active Pharma Sciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Solara Active Pharma Sciences Limited total assets.
Liquidity & Leverage Metrics
Solara Active Pharma Sciences Limited Total Liabilities Ratios Explained
Solara Active Pharma Sciences Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.00 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Solara Active Pharma Sciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Solara Active Pharma Sciences Limited (2017–2025)
The table below shows the annual total liabilities of Solara Active Pharma Sciences Limited from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs11.35 Billion ≈ $122.74 Million |
-19.76% |
| 2024-03-31 | Rs14.14 Billion ≈ $152.96 Million |
+1.27% |
| 2023-03-31 | Rs13.97 Billion ≈ $151.04 Million |
-1.49% |
| 2022-03-31 | Rs14.18 Billion ≈ $153.33 Million |
+38.89% |
| 2021-03-31 | Rs10.21 Billion ≈ $110.40 Million |
-3.99% |
| 2020-03-31 | Rs10.63 Billion ≈ $114.99 Million |
+6.35% |
| 2019-03-31 | Rs10.00 Billion ≈ $108.12 Million |
-5.06% |
| 2018-03-31 | Rs10.53 Billion ≈ $113.89 Million |
+31911263.64% |
| 2017-03-31 | Rs33.00K ≈ $356.88 |
-- |
About Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arr… Read more